Proteostasis, the controlled balance of protein synthesis, folding, assembly, trafficking and degradation, is a paramount necessity for cell homeostasis. Impaired proteostasis is a hallmark of ageing and of many human diseases. Molecular chaperones are essential for proteostasis in eukaryotic cells, and their function has traditionally been linked to protein folding, assembly and disaggregation. More recent findings suggest that chaperones also contribute to key steps in protein degradation. In particular, Hsp70 has an essential role in substrate degradation through the ubiquitin-proteasome system, as well as through different autophagy pathways. Accumulated knowledge suggests that the fate of an Hsp70 substrate is dictated by the combination of partners (cochaperones and other chaperones) that interact with Hsp70 in a given cell context.
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Eukaryotic cells have evolved numerous biological pathways to control the delicate balance of the synthesis, folding, trafficking and degradation of intra-and extracellular proteins. Evidence increasingly suggests that exposure to environmental stress and ageing lead to imbalance of this protein homeostasis network (proteostasis), which compromises cell integrity and stress resistance [1] and contributes to the onset of pathologies that include neurodegenerative disorders and cancer [2] . Molecular chaperones are at the heart of proteostasis in eukaryotic cells, given their essential roles in protein folding and degradation pathways [3] . There are various chaperone families (sHsp, Hsp40, Hsp60, Hsp70, Hsp90, Hsp100 and Hsp110) and their function is traditionally linked to protein folding and assembly [4] and to disaggregation of protein aggregates [5] . Later evidence showed that chaperones have a dual function in proteostasis, as they also contribute to key steps in protein degradation [6] (Fig. 1A ). Chaperone interaction with other chaperones or with cochaperones dictates the fate of the chaperone : substrate complex, tilting it towards substrate folding or degradation through either of the general protein degradation pathways, the ubiquitinproteasome system (UPS) or autophagy (Fig. 1B) .
Hsp70 is a nanomachine that uses its ATP hydrolysis-fuelled conformational changes to assist protein folding, disaggregation and degradation. It is now clear that Hsp70 acts as a central hub in cell proteostasis. Current knowledge allows discrimination of four major protein degradation pathways in mammalian cells. These include the UPS and three major Abbreviations CAEMI, chaperone-assisted endosomal microautophagy; CAMA, chaperone-assisted macroautophagy; CASA, chaperone-assisted selective autophagy; CHIP, carboxyl terminus of Hsp70-interacting protein; CMA, chaperone-mediated autophagy; CMA-TC, CMA translocation complex; CTD, C-terminal-most Hsp70 domain; CUPS, chaperone-assisted ubiquitin-proteasome pathway; EGFR, epidermal growth factor receptor; Hsc, heat shock cognate protein; LE, late endosomal; MLK3, mixed-lineage kinase 3; MVB, multivesicular bodies; NBD, nucleotide-binding domain; NEF, nucleotide exchange factors; TPR, tetratricopeptide repeat; SBD, substrate-binding domain; Ubl, ubiquitin-like; UPS, ubiquitin-proteasome system. types of autophagy: macroautophagy, microautophagy and chaperone-mediated autophagy. The pivotal role of a 70-kDa heat shock protein in the specific degradation of some intracellular proteins was acknowledged by the early definition of the pathway as chaperonemediated autophagy (CMA) [7] . Hsp70 can also provide specificity to the rest of the protein degradation pathways in certain cellular contexts. Here, we propose the following terms to highlight this direct implication of Hsp70; chaperone-assisted ubiquitin-proteasome pathways degradation (CUPS), chaperone-assisted endosomal microautophagy (CAEMI) and chaperoneassisted macroautophagy [CAMA; originally termed as chaperone-assisted selective autophagy (CASA) [8] or BAG3-mediated macroautophagy [9] ]. A wide variety of cellular proteins are degraded through these Hsp70-assisted pathways (Table 1 ). The many functions of Hsp70 are possible due to its isoforms and its collaboration with a variety of chaperones and cochaperones that direct it to these specific processes (Fig. 1B) [10].
We will review current knowledge of Hsp70-assisted protein degradation pathways, with special focus on the role of cochaperones. Hsp70 is often referred to as the triage chaperone [11] to acknowledge an active role in dictating the fate of protein substrates. Additionally, several cochaperones have also been described to hold this triage attribute independently [12] [13] [14] [15] . Here, we envision a model in which Hsp70 acts as a 'multiple socket'. In this model, Hsp70 provides the physical platform, with different binding domains, to which different chaperones and cochaperones can bind. The combination of interactors and the cooperation or competition among them dictates the fate of Hsp70 protein substrates.
Hsp70 domain organization and structure
The Hsp70 family of molecular chaperones have central roles in all aspects of proteostasis, from protein folding to disaggregation and degradation [16] . Hsp70 chaperones are highly conserved in all kingdoms. As general folders, they can interact with most proteins in their unfolded, misfolded or aggregated states, and can actively unfold, solubilize, and reactivate alreadyformed, stable protein aggregates [16] [17] [18] [19] . With the help of other cochaperones, some Hsp70 recognize a limited set of native proteins, and regulate or even redefine their activity [20, 21] .
Although the prokaryotic system has a single Hsp70 (the archetypical DnaK), the number of genes has expanded in eukaryotes, which express distinct Hsp70 isoforms in different physiological conditions and subcellular locations ( Table 2 ). The human genome encodes 13 Hsp70 isoforms [22] ; three are constitutively expressed, heat shock cognate protein (Hsc70; HSPA8, which accumulates in cytosol and the nucleus), Bip (HSPA5, endoplasmic reticulum) and mortalin (HSPA9, mitochondrial). The expression of other Hsp70, particularly Hsp70-1 (HSPA1A/B), is inducible (after cell stress).
Hsp70 has two basic domains (Fig. 2) ; the N-terminal, nucleotide-binding domain (NBD; 45 kDa) belongs structurally to the actin/hexokinase fold, a V-shaped structure composed of two subdomains that enclose the ATP-binding site. The NBD controls the conformational changes of the second domain, the substrate-binding domain (SBD; 25 kDa), which is built of two subdomains, a b-sheet domain (SBDb) or base, and a a-helical (SBDa) or Lid domain. The SBD recognizes and traps a motif present every 30-40 residues in most proteins; this short five-residue motif is enriched in hydrophobic amino acids and is flanked by regions with predominantly positively charged residues [23] . This type of hydrophobic region is usually found in the protein core and its exposure signals a misfolded conformation. The SBD adopts two very different conformations, open and closed, controlled by the NBD (Fig. 2) . ATP binding to the NBD induces the open conformation by separating the base and Lid subdomains. In this conformation, the SBD is in contact with the NBD and has low affinity for the substrate. The Hsp70 closed conformation is achieved after ATP hydrolysis; the NBD induces a change in the SBD such that the base and Lid subdomains come closer together and trap the substrate. SBD structural rearrangements are transmitted from the NBD via a flexible, conserved linker that contacts the NBD in the open state and detaches in the closed conformation (Fig. 2) .
Hsp70 function is fine-tuned by the cooperation of a variety of cochaperones. Two groups of cochaperones are essential for the Hsp70 functional cycle; these are the J-protein family that comprises the Hsp40 chaperones [24] and the nucleotide exchange factors (NEF) [25] (Fig. 2) . J-proteins accelerate ATP hydrolysis and thus potentiate the closed conformation, whereas the NEF promote ADP/ ATP exchange and thus, the open conformation. Both groups interact with Hsp70 through its NBD. The BAG proteins (Bcl-2-associated athanogene) are NEF that use a conserved BAG domain to interact with the interface formed by NBD subdomains IB and IIB to promote nucleotide cycling (Fig. 2) [26]. As we will discuss below, Hsp70 interaction with BAG1 or BAG3 is an illustrative example of how binding to distinct cochaperones respectively determines whether a given polyubiquitinated protein will be driven to the proteasomal or to the autophagic degradation pathway [27] . The C-terminal-most Hsp70 domain (CTD) bears an EEVD amino acid motif that interacts with distinct cochaperones, which in turn guide Hsp70-bound substrate towards folding or degradation [28, 29] .
Implication of Hsp70 in protein degradation pathways
Hsp70 and protein degradation by the chaperone-assisted ubiquitin-proteasome pathway (CUPS)
Chaperone-assisted UPS involves the ubiquitination of a chaperone-bound substrate and its subsequent [121] sorting to the proteasome. The UPS is a mechanism in the cytosol that tags proteins with one or more covalently bound ubiquitin molecules, leading to their entry into the proteasome and subsequent degradation [30] .
Most proteasome substrates are proteins with a short half-life, and include critical regulatory proteins involved in cell division, signalling and transcription [31] . Hsp70 and Hsp90 link chaperone function to the UPS [32] , and can intervene in chaperone-assisted sorting to the proteasome during initial recognition, substrate delivery and docking at the proteolytic complex. The cochaperone carboxyl terminus of Hsp70-interacting protein (CHIP) links these chaperones and the UPS during protein quality control [33, 34] . CHIP is a dimeric protein with an N-terminal tetratricopeptide repeat (TPR) domain that mediates CHIP interaction with the C-terminal EEVD motif in both Hsp70 and Hsp90 [35] . CHIP modulates chaperone function by blocking the ATPase cycle and inhibiting chaperone protein folding activity. The CHIP C-terminal domain has a U-box domain with E3 ubiquitin ligase activity. CHIP acts as a scaffold that positions the chaperone substrate near the Ubc4/5 family stress-associated E2 ubiquitin-conjugating enzymes [12] . CHIP is thus both a cochaperone and an E3 ubiquitin ligase [36] .
The Hsp70 NEF BAG1 (Bcl-2-associated athanogene 1) also has a prominent role as a UPS-associated cochaperone. BAG1 was initially identified as a binding partner of the anti-cell death protein Bcl-2, but was later found to bind Hsp70 NBD via its C-terminal BAG domain. This binding stimulates ADP release and substrate unloading from the chaperone. BAG1 also has an ubiquitin-like domain (Ubl) that can associate with the proteasome [37-39], which suggests that BAG1 can bind simultaneously to Hsp70 and to the proteasome, acting as a coupling factor between these molecules.
In summary, CHIP and Ubc4/5 mediate ubiquitination of chaperone substrates presented by Hsp70 (or Hsp90); the cochaperone BAG1 then connects Hsp70 to the proteasome and induces release of Hsp70 substrates near the proteasome, facilitating their degradation [40] .
Chaperone-mediated autophagy (CMA)
Chaperone-mediated autophagy was the first of the chaperone-assisted pathways to be described. It was initially defined as the role of a 70-kDa heat shock protein in the specific degradation of intracellular proteins [7] . It was later established that this lysosomal degradation pathway is stimulated specifically by the Hsc70 isoform. . An intralysosomal form of Hsc70 (Lys-Hsc70) is needed for efficient uptake of cytosolic proteins into the lysosome [47, 48] . This Lys-Hsc70 seems to exert the driving force for substrate translocation by trapping the substrate protein and pulling it to the interior of the lysosome, where it is further degraded by proteases.
Hsc70 associates with the cytosolic side of the lysosomal membrane, where it binds to CMA pathway substrates. Results from coimmunoprecipitation and colocalization studies indicate that Hsc70 forms complexes at the lysosomal membrane with other molecular chaperones and cochaperones, including Hsp90, Hsp40, Hop, Hip and BAG1 [46,49,50]. The exact nature of these Hsc70-protein complexes and their precise mechanistic role in CMA remain to be determined.
The role of Hsc70 in chaperone-assisted endosomal microautophagy (CAEMI)
Microautophagy involves direct entrapment of cytosolic components by invagination of the lysosomal membrane, followed by degradation of the cargo-containing vesicle. Although there was evidence of this process decades ago [ A specific form of microautophagy that involves late endosomes (CAEMI) was identified in mammalian cells [58] . In this form of microautophagy, cytosolic proteins are trapped in late endosomal (LE) vesicles during the formation of multivesicular bodies (MVB), a process that relies on electrostatic binding of the Hsc70 SBD to endosomal acidic phospholipids [58, 59 ]. This interaction site was recently narrowed down to a cluster of positive charges on the Hsc70 lid domain [60] . Hsc70 has a prominent role in mediating the selection of CAEMI-specific protein substrates. Substrates need not be unfolded for degradation through this pathway [58] . The selection of specific protein substrates for CAEMI degradation relies, as in CMA, on recognition of substrates that bear the KFERQ motif, and appears to involve Hsc70 oligomerization [61] . Selective forms of CAEMI have been described in Drosophila, which involves endosomal microautophagy through Hsc70 recognition of substrates in synaptic protein turnover to maintain optimal function [62] . CAEMI was also identified in starvation conditions in Drosophila [63] and the prominent role of Hsc70 in the CAEMI pathway has been confirmed.
The detailed molecular mechanism that underlies CAEMI, or how the Hsc70 : substrate complex is specifically targeted to CMA or CAEMI, is not yet fully understood. Complex composition is expected to be crucial for targeting selectivity, and cochaperones are again thought to be key components [61] . Lack of extensive knowledge of CAEMI resides in the fact that it shares many mechanistic features with CMA, including Hsc70 involvement in substrate recruitment, as well as selectivity for substrates with the KFERQ motif. Future efforts should focus on developing systems to allow differential analysis to better define the precise requirements of each pathway and to fully understand their mechanistics.
Hsp70 in chaperone-assisted macroautophagy (CAMA)
Macroautophagy is conserved from yeast to humans [64] . It was long considered a nonspecific bulk degradation process in which cytosolic components are enclosed by the autophagosome, a double-membrane vesicle that subsequently fuses with a lysosome for degradation of its cargo [65] . It was later shown that this process also uses mechanisms that target specific substrates [66] . Disposal via this pathway of aggregateprone proteins, which have been linked to human disease, has attracted a great deal of interest [67] .
Specificity is dictated by a presentation complex that delivers ubiquitinated proteins to the forming phagophore for further degradation. In this complex, Hsp70 has a central role, as it interacts with the substrate and nucleates a number of interactions basic for protein presentation, and for that reason, this specific form of macroautophagy was designated as CASA [8] . The cochaperone BAG3 acts as a molecular switch that coordinates the activity of Hsp70 and the small heat shock protein HspB8. BAG3 is one of the largest BAG proteins and bears several protein-protein interaction motifs (a WW domain, various PXXP motifs and two IPV motifs) [68] .
HspB8 overexpression in cultured cells prevents accumulation of aggregation-prone proteins. HspB8 forms a stable complex with BAG3 that is essential for its activity. BAG3 and HspB8 expression affect levels of LC3-II, an essential component of phagophores and autophagosomes, and macroautophagy inhibitors decrease HspB8/BAG3-induced degradation of aggregation-prone proteins. These findings suggest that HspB8/BAG3 has a central role in specific macroautophagy [69] . BAG3 interacts with Hsp70/Hsc70 [70] . Hsc70, BAG3 and HspB8 form a ternary complex, in which BAG3 acts as a link between Hsp70 and HspB8, in the first case via the BAG domain and in the second, through its IPV motifs. The chaperone-associated ubiquitin ligase CHIP also associates with the Hsp70 : BAG3 : HspB8 complex, in this case through Hsp70 [8, 71] .
This preloading complex containing ubiquitinated proteins and CHIP : Hsp70 : BAG3 : HspB8 is then recruited by the ubiquitin-binding protein p62/ SQSTM1, which binds simultaneously to LC3 and to polyubiquitinated proteins [27] . The lipidated LC3 form (LC3-II) associates to the phagophore membrane. This simultaneous binding could trigger enclosure of the aggregated protein within a fully fused autophagosome for further degradation in the lysosome [72] .
Progressive loss of CUPS activity during ageing appears to be compensated by a CAMA increase accompanied by a switch from BAG1 to BAG3 expression [27, 73] , which supports the idea that depending on circumstances, Hsp70 partners dictate the fate of the substrate. BAG3 also interacts with the microtubule-motor dynein and selectively directs Hsp70 substrates to the aggresome through a mechanism that does not depend on substrate ubiquitination to dispose of the aggregated proteins through macroautophagy [74] . To acknowledge the important role of BAG3 in this pathway, this form of specific macroautophagy was also designated as BAG3-mediated selective autophagy [9] . Here we propose the term CAMA to unify the two previous terms (CASA and BAG3-mediated selective autophagy).
Hsp70-assisted protein degradation and disease
Cancer, neurodegeneration and myopathies are disease conditions in which proteostasis is compromised. There are numerous examples of Hsp70-assisted protein degradation defects in these disease conditions, which suggest potential for Hsp70 as a therapeutic target. As examples, we will discuss some representative studies in which alterations in Hsp70 complex components involved in protein degradation pathways derive in disease conditions. Hsp70 inhibits apoptosis and has a role in resistance to cancer chemotherapy [75] . It is located in the membranes of tumour cell endosomal/lysosomal compartments and inhibits lysosomal permeabilization induced by diverse stimuli [76] . CHIP overexpression blocks oncogenic signalling pathways by degrading proteins such as epidermal growth factor receptor (EGFR) or mixed-lineage kinase 3 (MLK3) [77, 78] . Together with BAG1, CHIP is also involved in proteasomal degradation of immature BCR-ABL [14] . CHIP overexpression promotes telomerase activity by promoting hTERT degradation, which could open new pathways for modulating telomerase activity in cancer. In contrast, CHIP overexpression can induce proteasomal Fig. 3 . Scheme of the 'multiple socket' model for Hsp70 function. In this model, the fate of a given Hsp70-bound substrate is determined by the different chaperones and cochaperones bound to Hsp70 in a given cellular context. The binding site for KFERQ-containing substrates and for classical substrates is expected to be different. BAG proteins and Hsp100 [100] interact with the interface formed by the NBD subdomains IB and IIB. HIP uses its TPR domain to interact with Hsp70 NBD [101] , in a region that partially overlaps the BAG-binding domain. Hsp40 binds to the cleft between NBD subdomains IA and IIA [102] . HOP [103] and CHIP interact through a TPR domain with the CTD (through the EEVD sequence).
degradation of proteins that mediate apoptosis (ASK1) [79] and tumour suppressor proteins (PTEN and p53) [80, 81] . This implies that the potential of CHIP-based therapies in cancer is complex, given that CHIP overexpression promotes degradation of a wide variety of proteins with antagonistic roles in cancer.
In neurodegenerative conditions, CHIP can prevent the accumulation of aberrant proteins such as a-synuclein in Parkinson's disease [82, 83] and tau in Alzheimer's disease [84, 85] . In addition, CHIP association with expanded polyglutamine proteins promotes their degradation through the proteasome [86] . In motor neurons, expression of HspB8 mutants leads to neurite degeneration [87] . Hsp70 itself stabilizes lysosomes and reverses Niemann-Pick disease-associated lysosomal pathology [88] , although the mechanism that underlies this stabilization is unclear.
Over the years, a number of studies have established a relationship between abnormal macroautophagy and different forms of myopathy. BAG3 is essential for maintaining muscle survival and BAG3-deficient mice develop severe myopathy [89] . In humans, a point mutation in BAG3 (P209L) causes childhood muscular dystrophy and cardiomyopathy [90] . This mutant form of BAG3 is unable to induce filamin degradation [8] . Mutations in HspB8, associated with motor and neuronal diseases, are proposed to relate to macroautophagy defects [69] . The HspB8 mutation that causes hereditary distal motor neuropathy is accompanied by macroautophagy defects due to impaired lysosomal delivery of autophagosomes [91] .
Given the central role of protein degradation in proteostasis, alterations in Hsp70-assisted degradation pathways are being described for an increasing number of human disease conditions (e.g. the relationship between the UPS and cardiovascular disease [92] ). Future work will help decipher the effects of altered protein degradation on disease progression, an essential first step for adequate identification of therapeutic targets in these pathways.
Conclusions and perspectives
Although the importance of Hsp70 in protein folding and disaggregation has been well established for decades, more recent evidence confirms its relevance in protein degradation pathways. We envision a model in which Hsp70 acts as a 'multiple socket' (Fig. 3) providing a physical platform for the simultaneous interaction with other chaperones and cochaperones. The set of distinct connections established through the different Hsp70 domains determines the fate of the Hsp70-bound substrate, that is folding, disaggregation or any of several protein degradation pathways. There are various regulatory levels for fine-tuning Hsp70 function. The involvement of distinct Hsp70 isoforms can be crucial, for example CMA and CAEMI appear to involve Hsc70 exclusively, and not Hsp70. Moreover, the Hsp70-bound substrate can have an effect on its own fate (e.g. KFERQ-containing substrates are degraded through CMA and CAEMI). The finest level of regulation relies on the chaperone/cochaperone combinations that interact with Hsp70/Hsc70 and the cooperating or competing relations they establish among them at any given time. Additionally, other chaperones like Hsp90 can contribute to the regulation of Hsp70-mediated degradation by competing for binding to substrates and cochaperones [93, 94] .
Structural data for the many Hsp70-containing complexes involved in protein degradation will be essential for understanding the mechanistic and regulatory details for each pathway, and for potential manipulation of the system. Recent advances in cryoelectron microscopy offer great opportunities for detailed structural characterization of Hsp70-protein complexes [95] [96] [97] . Efforts should also be made to define how Hsp70-containing complexes organize and operate in situ in different physiological and pathological conditions. New developments in cryoelectron tomography [98, 99] 
